Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

Here's a legitimate question that I have not heard anyone ask yet that I think deserves some real attention. Here goes:

Assuming that Navidea is able to get FDA approval in June and October AND is able to get EU approval by the end of 2014, how much will the company's revenue be in 2015?

On the low end and on the high end, what are some reasonable estimates?

I would think at least $30-40 million on the high end, but perhaps it is much greater than this. The SLN designation will be worth far more in sales than breast and melanoma cancer. There must be posters here and elsewhere who have a solid idea. Please advise. This is a forecast worth exploring.